Intima Bioscience is a clinical stage gene and cell therapy company focused on curative intent in solid tumor cancer.

Intima Bioscience

Intima Bioscience | 892 followers on LinkedIn. A clinical stage gene and cell therapy company
focused on curative intent in solid tumor cancer

Principal Scientist, stem cell lead at Intima Bioscience

Francesco Paonessa

Senior Scientist at Intima Bioscience

Alberto Bravo-Blas, DVM, MSc, PhD

CSO at Intima Bioscience

Tom Henley

Principal Scientist, Immuno-oncology

Flor Cano

Viewport Meta

IPhone / Mobile Compatible

Google Tag Manager

Google Font API

Google Analytics

WordPress

Global Site Tag

DoubleClick.Net

US Privacy User Signal Mechanism

Cloudflare CDN

Senior Vice President & Head of Small Molecule Discovery

Ashvin Gavai

Chief Scientific Officer

Campbell Murray

President & Chief Operating Officer

Alessandro Riva

Chief Executive Officer

City of New York Companies With Less Than $500M in Revenue (Top 10K)

City of New York Companies With Fewer Than 100 Employees (Top 10K)

New York Biotechnology Companies

New York Companies With Less Than $500M in Revenue (Top 10K)

Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures.

With its Molecular and Cell Therapy (MCT) GMP gene and cell therapy production facility, Intima Bioscience is undertaking a clinical trial at the University of Minnesota Masonic Cancer Center.

It is headquartered in New York City.

Venture Round - Intima Biosciences

New York

United States

North America

Intima Biosciences

Intima Bioscience Appoints Alessandro Riva, M.D., as Chief Executive Officer

India

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 20, 2024 2:51 PM	7b8602bb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 20, 2024 2:51 PM	605864e5
crunchbase trigger	general	Nov 20, 2024 2:51 PM	ab2414c2
crunchbase profile	general	Nov 20, 2024 2:54 PM	7e27ec52
li profile	general	Nov 20, 2024 2:51 PM	73aa09e6
translate crunchbase fundingrounds	general	Nov 20, 2024 3:34 PM	50ec6a31
peers	general	Nov 20, 2024 2:51 PM	25255011
news basic	general	Nov 20, 2024 2:51 PM	f978e125
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

INTI

COM:INTIMABIOSCIENCE

Intima Bioscience